Fira Barcelona Gran Via
Spain, 24-26/10/2023
IASIS PHARMA participated with great success in the Global Exhibition of the Pharmaceutical industry, CPhI.
For 2023, the exhibition was held on October 24 & 26, 2023 at Barcelona’s Gran Via Exhibition Center.
The organizers registered thousands of visitors and over 2,000 exhibitors, while hundreds were the professionals of the pharmaceutical industry who visited the IASIS PHARMA exhibition stand, receiving interesting information about the company’s unique and wide product portfolio.
More specifically, the company projected:
- IASIS PHARMA’s leading position in the Nitrofurantoin market, presenting the product in 4 forms: tabs (IR), capsules (IR, PR), oral suspension, with complete licensing procedures in 25 countries and 36 MAs (Marketing Authorizations).
- Its specialization in Contract Manufacturing Services in its 4 new, state-of-the-art production facilities.
- The wide range of prescription drugs in the form of effervescent tablets.
- An extremely interesting range of new products in Oral Suspension form in niche markets – New Product Pipeline.
IASIS PHARMA had the pleasure of hosting colleagues from its newly established company, IASIS PHARMA ROMANIA which is the latest milestone in the Group’s ongoing history.
IASIS PHARMA presented audio-visual material about the company’s new, state-of-the-art production facilities in Koropi, Attica, as well as the Mastic Research and Development Center of Chios, the construction of which has been completed and its operational work has already begun.
Also, during the three-day event, the IASIS PHARMA Management team succeeded in further strengthening its international partnerships, as well as laying the foundations for new ones, further strengthening the company’s international presence.
Finally, after its successful participation in CPhI Fira Barcelona Gran Via 2023, IASIS PHARMA renews the appointment with the global pharmaceutical industry for 8 – 10/10/2024 at CPhI Fiera Milano, Italy.
